Reneuron Group (RENE)

 

Latest News

Neil Woodford 'very confident' he can deliver 10%-plus yearly returns

Woodford Patient Capital's performance has picked up over the last three months and Neil Woodford is optimistic. Marina...

Posting of Annual Report and Notice of AGM

RNS Number: 3171N ReNeuron Group plc 07 August 2017 AIM: RENE 7 August 2017 ReNeuron Group plc ("ReNeuron" or "the Company") Posting of Annual Report and Accounts and Notice of AGM ReNeuron Group plc (AIM: RENE), a leading UK-based stem cell therapy development company, announces that its Annual Report and Accounts for the year ende...

Second Price Monitoring Extn

RNS Number: 2036N ReNeuron Group plc 04 August 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined p...

Price Monitoring Extension

RNS Number: 2027N ReNeuron Group plc 04 August 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the executio...

All News

DateHeadlineSource
07-08-17Neil Woodford 'very confident' he can deliver 10%-plus yearly returnsMoney Observer
07-08-17Posting of Annual Report and Notice of AGMRNS
04-08-17Second Price Monitoring ExtnRNS
04-08-17Price Monitoring ExtensionRNS
25-07-17Appointment of joint brokerRNS
19-07-17Board changeRNS
29-06-17ReNeuron widens FY pretax lossStockMarketWire
29-06-17Preliminary ResultsRNS
19-06-17ReNeuron says FDA okays cryopreserved hRPC formulationStockMarketWire
19-06-17FDA approves cryopreserved hRPC formulationRNS
08-06-17Notification of Preliminary ResultsRNS
05-06-17ReNeuron gets favourable feedback from US FDAStockMarketWire
05-06-17Positive FDA feedback on proposed Phase III studyRNS
18-05-17ReNeuron presents positive exosome dataStockMarketWire
18-05-17Presents positive exosome data at major conferenceRNS
11-05-17ReNeuron awarded £1.8m grant from Innovate UKStockMarketWire
11-05-17Awarded major UK cell therapy manufacturing grantRNS
05-05-17Presents new exosome data at major conferenceRNS
21-04-17ReNeuron updates on ophthalmology programmesStockMarketWire
21-04-17ReNeuron updates on clinical strategy in stroke disabilityStockMarketWire
21-04-17Update on clinical strategy in stroke disabilityRNS
21-04-17Update on progress in ophthalmology programmesRNS
01-03-17Block Listing Review and Total Voting RightsRNS
15-02-17ReNeuron featured in BBC documentaryRNS
07-02-17Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
07-02-17Director Share PurchaseRNS
01-02-17ReNeuron Group to present at the Shares Spotlight Evening in Edinburgh on 15 February 2017StockMarketWire
14-12-16Director Share PurchaseRNS
05-12-16ReNeuron widens H1 pretax lossStockMarketWire
05-12-16ReNeuron reports positive results in Phase II Stroke TrialStockMarketWire
05-12-16Interim ResultsRNS
05-12-16Reports Positive Results in Phase II Stroke TrialRNS
14-11-16Notification of Interim ResultsRNS
14-10-16ReNeuron Group Plc to present at the Shares Investor Evening in London on 27th October 2016StockMarketWire
05-10-16Notification of Major Interest in SharesRNS
22-09-16Block Listing Review and Total Voting RightsRNS
06-09-16ReNeuron passes AGM resolutionsStockMarketWire
06-09-16Result of AGMRNS
06-09-16AGM Trading UpdateRNS
05-08-16Posting of Annual Report and Notice of AGMRNS

RSS feeds

  • Editorial news feed for LSE:RENE Editorial
  • Regulatory news feed for LSE:RENE Regulatory